[C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure]

Lyankis López1, Kaduo Arai, Esther Giménez

  • 1Asociación Cardiovascular Centro-Occidental (ASCARDIO), Escuela de Medicina, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Lara, Venezuela.

Insights

Interleukin-6 (IL-6) and C-reactive protein (CRP) serum levels correlate with Chagas disease progression. Elevated IL-6 is linked to disease stage, while CRP rises in advanced phases, indicating potential prognostic value for cardiac function.

Area of Science:

  • Cardiology
  • Immunology
  • Infectious Diseases

Context:

  • Chagas disease is a leading cause of myocarditis in Latin America.
  • Chronic chagasic cardiomyopathy affects 25% of patients, leading to heart failure and arrhythmias.
  • Serum biomarkers like C-reactive protein (CRP) and interleukin-6 (IL-6) have prognostic value in other cardiomyopathies.

Purpose:

  • To investigate the relationship between serum CRP and IL-6 levels and the developmental stage of Chagas disease.
  • To assess the potential of these biomarkers in predicting disease progression and cardiac function deterioration.

Summary:

  • A study of 64 Chagas disease patients and 20 healthy controls measured serum CRP and IL-6 levels.
  • Results showed a significant association between Chagas disease stage and IL-6 levels.
  • CRP levels increased in the most advanced disease phase, and high IL-6 levels correlated with increased left ventricular mass index and male sex.

Impact:

  • Serum IL-6 and CRP levels may serve as valuable prognostic indicators for Chagas disease progression.
  • These biomarkers could aid in assessing cardiac function and guiding clinical management.
  • Understanding these relationships can improve patient outcomes and disease monitoring.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...